Clinical Trials List
Protocol NumberCOEB071X2103
2013-09-15 - 2016-07-11
Phase I/II
Terminated1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- - - Division of General Internal Medicine
- Ann-Lii Cheng Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- Shang-Ju Wu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
70 participants
